Changing Diabetes® World Tour

Novo Nordisk A/S8,304 enrolled

Overview

This study is conducted in the Middle East, Northern Africa and Europe. The aim of this study is to contribute to the design of a simple screening strategy for countries in scope, by exploring the association between risk factors and undiagnosed diabetes in a screening study.

Study Type

OBSERVATIONAL

Enrollment

8,304

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Interventions

No treatment givenOTHER

The screening test includes a combination of a risk assessment questionnaire and biochemical tests.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Informed consent obtained Exclusion Criteria: * Subjects with known diabetes (exception: women with a history of gestational diabetes should not be excluded) * Pregnant women or women who have given birth within less than a month * Subjects suffering from severe illness * Subjects with the inability to read and understand the information given (either due to illiteracy or vision problems) and therefore unable to give an informed consent * Subjects with mental impairment * Subjects treated with systemic cortico-steroids

Locations (3)

Novo Nordisk Investigational Site

Paço de Arcos, Portugal

Novo Nordisk Investigational Site

Riyadh, Saudi Arabia

Novo Nordisk Investigational Site

Dubai, United Arab Emirates

Outcomes

Primary Outcomes

HbA1c (Glycosylated Haemoglobin) level

Time frame: measured at the screening visit (only 1 visit during the 2 weeks stay of the bus in each country)

Secondary Outcomes

Number of subjects with diabetes (type 1 and 2)

Time frame: measured at the screening visit (only 1 visit during the 2 weeks stay of the bus in each country)

The presence of retinopathy

Time frame: measured at the screening visit (only 1 visit during the 2 weeks stay of the bus in each country)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.